Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MEV90 of ropivacaine 0.75% for ultrasound-guided transmuscular quadratus lumborum block in unilateral percutaneous nephrolithotomy
2019-002200-40Phase 4Completed
- Sponsor
- Zealand University Hospital
- Start
- May 2019
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of ropivacaine in postoperative pain, sponsored by Zealand University Hospital. Primary endpoint: Pain intensity 30 minutes after PACU arrival. Started May 2019; status: completed.
02
Drugs
ropivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on 2019-002200-40.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2019-002200-40.